
23andMe nears two drug deals as company enters Chapter 11
Patents from the company's drug-development unit could be key to raising fresh cash as Big Pharma companies look for new drugs to replace billions of dollars from drugs losing patent protections. 23andMe's drug-development unit — an outlet for the …